Medicare Legislation Provides Incentives for ePrescribing


By Neil Versel, contributing editor

July 22, 2008 | Digital HealthCare & Productivity | The Medicare program could save as much as $156 million over the next five years from error avoidance and efficiency gains from a newly authorized electronic prescribing incentive program, federal officials say.

Legislation adopted last week to halt a scheduled 10.6 percent Medicare physician fee cut also includes financial incentives for ePrescribing. Eligible physicians and other authorized prescribers will receive 2 percent bonuses for writing electronic scripts for Medicare beneficiaries in 2009 and 2010. The bonus payments drop to 1 percent in 2011 and 2012 and to 0.5 percent in 2013.

But beginning in 2012, those who are not using ePrescribing technology for their Medicare patients will be subject to fee reductions. “We hope that we don’t get to the penalty, that we have ubiquitous ePrescribing by 2013,” American Academy of Family Physicians president James King said Monday in a conference call organized by the Department of Health and Human Services (HHS).

King said about 9 percent of AAFP members currently are ePrescribing, which means they are sending true electronic orders and messages to pharmacies, not computer-generated faxes.

Congress passed the Medicare bill over the veto of President Bush, who objected to reduced payments to third-party payers in the Medicare Advantage managed care program. The administration strongly supported the ePrescribing portion of the legislation, however.

“[ePrescribing] was not one of the reasons for the veto,” acting Centers for Medicare and Medicaid Services (CMS) administrator Kerry Weems said during the conference call with reporters.

“Advancing ePrescribing has been a top priority of this administration,” added HHS secretary Mike Leavitt.

Leavitt said HHS arrived at the $156 million figure by extrapolating to the Medicare population an Institute of Medicine (IOM) estimate that 1.5 million Americans are injured by prescribing errors each year and other studies suggesting that pharmacists make 150 million unnecessary phone calls annually to providers to clarify prescription orders. According to Leavitt, there are as many as 530,000 adverse drug events involving Medicare patients every year.

Weems said ePrescribing technology runs about $3,000 per prescriber in one-time acquisition costs, plus ongoing maintenance fees. He was not sure if the financial incentives would be enough to offset these expenses, as CMS still has to develop rules for administering the program. Weems said CMS will publish the incentive schedule as part of the agency’s 2009 fee revisions due out in the fall. The bill replaces the planned 10.6 percent fee cut with a 0.5 percent increase for 2008 and 1.1 percent rise next year.

The new bill also authorizes a case-by-case “hardship” exemption from the ePrescribing penalties. King says the hardship waiver “makes us a little more comfortable with the legislation.”

Leavitt said CMS will hold a conference this fall to help Medicare providers work through some of the logistical and technical issues related to the incentive program. He did not offer further details.

 

 

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.